<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25330384</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>10</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors.</ArticleTitle><Pagination><StartPage>e110429</StartPage><MedlinePgn>e110429</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e110429</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0110429</ELocationID><Abstract><AbstractText>Flavonoids are widely distributed natural products with broad biological activities. Apigenin is a dietary flavonoid that has recently been demonstrated to interact with heterogeneous nuclear ribonucleoproteins (hnRNPs) and interferes with their RNA editing activity. We investigated whether apigenin possessed antiviral activity against enterovirus-71 (EV71) infection since EV71 infection requires of hnRNP proteins. We found that apigenin selectively blocks EV71 infection by disrupting viral RNA association with hnRNP A1 and A2 proteins. The estimated EC50 value for apigenin to block EV71 infection was determined at 10.3 &#xb5;M, while the CC50 was estimated at 79.0 &#xb5;M. The anti-EV71 activity was selective since no activity was detected against several DNA and RNA viruses. Although flavonoids in general share similar structural features, apigenin and kaempferol were among tested compounds with significant activity against EV71 infection. hnRNP proteins function as trans-acting factors regulating EV71 translation. We found that apigenin treatment did not affect EV71-induced nucleocytoplasmic redistribution of hnRNP A1 and A2 proteins. Instead, it prevented EV71 RNA association with hnRNP A1 and A2 proteins. Accordingly, suppression of hnRNP A1 and A2 expression markedly reduced EV71 infection. As a positive sense, single strand RNA virus, EV71 has a type I internal ribosome entry site (IRES) that cooperates with host factors and regulates EV71 translation. The effect of apigenin on EV71 infection was further demonstrated using a bicistronic vector that has the expression of a GFP protein under the control of EV71 5'-UTR. We found that apigenin treatment selectively suppressed the expression of GFP, but not a control gene. In addition to identification of apigenin as an antiviral agent against EV71 infection, this study also exemplifies the significance in antiviral agent discovery by targeting host factors essential for viral replication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Haishi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Yuanzi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiaoqing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Yayi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Renxiang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China; College of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Erguang</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076245">Heterogeneous Nuclear Ribonucleoprotein A1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034481">Heterogeneous-Nuclear Ribonucleoprotein Group A-B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067556">Internal Ribosome Entry Sites</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>7V515PI7F6</RegistryNumber><NameOfSubstance UI="D047310">Apigenin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D047310" MajorTopicYN="N">Apigenin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015967" MajorTopicYN="N">Gene Expression Regulation, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076245" MajorTopicYN="N">Heterogeneous Nuclear Ribonucleoprotein A1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034481" MajorTopicYN="N">Heterogeneous-Nuclear Ribonucleoprotein Group A-B</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067556" MajorTopicYN="N">Internal Ribosome Entry Sites</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25330384</ArticleId><ArticleId IdType="pmc">PMC4199717</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0110429</ArticleId><ArticleId IdType="pii">PONE-D-14-25246</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, et al. (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10: 778&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Ren L, Xiong Z, Li J, Xiao Y, et al. (2009) Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol 47: 2351&#x2013;2352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Shih SR (2013) Strategies to develop antivirals against enterovirus 71. Virol J 10: 28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3614426</ArticleId><ArticleId IdType="pubmed">23339605</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson SR, Sarnow P (2003) Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G is cleaved. Virology 315: 259&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">14592777</ArticleId></ArticleIdList></Reference><Reference><Citation>Junemann C, Song Y, Bassili G, Goergen D, Henke J, et al. (2007) Picornavirus internal ribosome entry site elements can stimulate translation of upstream genes. J Biol Chem 282: 132&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">17095505</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Stollar V, Li ML (2011) Host factors in enterovirus 71 replication. J Virol 85: 9658&#x2013;9666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196451</ArticleId><ArticleId IdType="pubmed">21715481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Shih SR, Pan M, Li C, Lue CF, et al. (2009) hnRNP A1 interacts with the 5' untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J Virol 83: 6106&#x2013;6114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2687368</ArticleId><ArticleId IdType="pubmed">19339352</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LL, Kung YA, Weng KF, Lin JY, Horng JT, et al. (2013) Enterovirus 71 infection cleaves a negative regulator for viral internal ribosomal entry site-driven translation. J Virol 87: 3828&#x2013;3838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3624201</ArticleId><ArticleId IdType="pubmed">23345520</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Li ML, Huang PN, Chien KY, Horng JT, et al. (2008) Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5' untranslated region and participates in virus replication. J Gen Virol 89: 2540&#x2013;2549.</Citation><ArticleIdList><ArticleId IdType="pubmed">18796723</ArticleId></ArticleIdList></Reference><Reference><Citation>Levengood JD, Tolbert M, Li ML, Tolbert BS (2013) High-affinity interaction of hnRNP A1 with conserved RNA structural elements is required for translation and replication of enterovirus 71. RNA Biol 10: 1136&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3849161</ArticleId><ArticleId IdType="pubmed">23727900</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai FJ, Lin CW, Lai CC, Lan YC, Lai CH, et al. (2011) Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins. Food Chem 128: 312&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">25212137</ArticleId></ArticleIdList></Reference><Reference><Citation>Jean-Philippe J, Paz S, Caputi M (2013) hnRNP A1: the Swiss army knife of gene expression. Int J Mol Sci 14: 18999&#x2013;19024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3794818</ArticleId><ArticleId IdType="pubmed">24065100</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh RK, Cooper TA (2012) Pre-mRNA splicing in disease and therapeutics. Trends Mol Med 18: 472&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3411911</ArticleId><ArticleId IdType="pubmed">22819011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Manley JL (2013) Misregulation of pre-mRNA alternative splicing in cancer. Cancer Discov 3: 1228&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3823817</ArticleId><ArticleId IdType="pubmed">24145039</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekenstein U, Soreq H (2013) Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles. Mol Cell Neurosci 56: 436&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">23247072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo CS, Chang SY, Chenier I, Filep JG, Ingelfinger JR, et al. (2012) Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Diabetes 61: 2597&#x2013;2608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3447919</ArticleId><ArticleId IdType="pubmed">22664958</ArticleId></ArticleIdList></Reference><Reference><Citation>Arango D, Morohashi K, Yilmaz A, Kuramochi K, Parihar A, et al. (2013) Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets. Proc Natl Acad Sci U S A 110: E2153&#x2013;2162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3683737</ArticleId><ArticleId IdType="pubmed">23697369</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27: 493&#x2013;497.</Citation></Reference><Reference><Citation>Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA (2002) Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 26: 182&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">12054895</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZH, Li CM, Ling P, Shen FH, Chen SH, et al. (2008) Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis 197: 854&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7109938</ArticleId><ArticleId IdType="pubmed">18279075</ArticleId></ArticleIdList></Reference><Reference><Citation>Biamonti G, Ruggiu M, Saccone S, Della Valle G, Riva S (1994) Two homologous genes, originated by duplication, encode the human hnRNP proteins A2 and A1. Nucleic Acids Res 22: 1996&#x2013;2002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308112</ArticleId><ArticleId IdType="pubmed">8029005</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreyfuss G, Kim VN, Kataoka N (2002) Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 3: 195&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">11994740</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Pallansch MA (1995) Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 39: 195&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Siafakas N, Markoulatos P, Stanway G (2002) Variability in molecular typing of Coxsackie A viruses by RFLP analysis and sequencing. J Clin Lab Anal 16: 59&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6807804</ArticleId><ArticleId IdType="pubmed">11835534</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh MT, Wang SW, Yu CK, Lin KH, Lei HY, et al. (2011) A single nucleotide in stem loop II of 5'-untranslated region contributes to virulence of enterovirus 71 in mice. PLoS One 6: e27082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3206083</ArticleId><ArticleId IdType="pubmed">22069490</ArticleId></ArticleIdList></Reference><Reference><Citation>Manthey JA, Grohmann K, Guthrie N (2001) Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem 8: 135&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">11172671</ArticleId></ArticleIdList></Reference><Reference><Citation>Orhan DD, Ozcelik B, Ozgen S, Ergun F (2010) Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol Res 165: 496&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">19840899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Pandey AK (2013) Chemistry and biological activities of flavonoids: an overview. The Scientific World Journal 2013: 162750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3891543</ArticleId><ArticleId IdType="pubmed">24470791</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti C, Genovese D, Santoro R, Stein ML, Orsi N, et al. (1990) Activities and mechanisms of action of halogen-substituted flavanoids against poliovirus type 2 infection in vitro. Antimicrob Agents Chemother 34: 460&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC171615</ArticleId><ArticleId IdType="pubmed">2159258</ArticleId></ArticleIdList></Reference><Reference><Citation>Superti F, Seganti L, Orsi N, Divizia M, Gabrieli R, et al. (1989) Effect of isoflavans and isoflavenes on the infection of Frp/3 cells by hepatitis A virus. Antiviral Res 11: 247&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">2552913</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait S, Salvati AL, Desideri N, Fiore L (2006) Antiviral activity of substituted homoisoflavonoids on enteroviruses. Antiviral Res 72: 252&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">16934879</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>